Th1 polarization and low-T3 syndrome are correlated with hyperleptinemia in hemodialysis patients

Journal of Nephrology

Volumn 22, Issue 4, 2009, Pages 515-522

  Liu, Mao Lin ^a   Huang, Zi Yan ^a   Zhong, Xiao Chun ^a   Liu, Su Hang ^a   Xu, Gang ^a   Jiang, Ting Ying ^a   Xi, Wei Wei ^b   Yan, Wei Qi ^b  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hemodialysis; Immune response; Leptin; Low T3 syndrome; Th1 Th2 polarization

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LEPTIN; LIOTHYRONINE; SOLUBLE INTERLEUKIN 2 RECEPTOR; THYROID HORMONE; THYROTROPIN; THYROXINE; CYTOKINE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERLEPTINEMIA; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLARIZATION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; TH1 CELL; TH2 CELL; THYROXINE BLOOD LEVEL; UREMIA; AGED; BIOSYNTHESIS; BLOOD; CELL POLARITY; EUTHYROID SICK SYNDROME; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CELL POLARITY; CYTOKINES; EUTHYROID SICK SYNDROMES; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; RENAL DIALYSIS; TH1 CELLS; THYROTROPIN; TRIIODOTHYRONINE;

EID: 70249142871     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. Immune system dysregulation in uremia. Semin Nephrol. 1994;14:253-260.
2. Nitta K, Akiba T, Kawashima A, et al. Characterization of Th1/Th2 profile in uremic patients. Nephron. 2002;91:492-495.
3. Beaurain G, Naret C, Marcon L, et al. In vivo T cell preactivation in chronic uremic hemodialyzed patients and non-hemodialyzed patients. Kidney Int. 1989;36:636-644.
4. Descamps-Latscha B, Jungers P. New molecular aspects of chronic uraemia and dialysis-related immunocompetent cell activation. Nephrol Dial Transplant. 1996;11(Suppl 2):121-124.
5. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol. 1997;15:297-322.
6. Botella-Carretero JI, Prados A, Manzano L, et al. The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal. Eur J Endocrinol. 2005;153:223-230.
7. Carrero JJ, Qureshi AR, Axelsson J, et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med. 2007;262:690-701.
8. Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005;16:2789-2795.
9. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67:1047-1052.
10. Jaroszynski AJ, Glowniak A, Chrapko B, et al. Low-T3 syndrome and signal-averaged ECG in haemodialysed patients. Physiol Res. 2005;54:521-526.
11. Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394:897-901.
12. Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol. 2002;72:330-338.
13. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093-1103.
14. Kokkinos A, Mourouzis I, Kyriaki D, Pantos C, Katsilambros N, Cokkinos DV. Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone. Endocrine. 2007;32:30-32.
15. Iglesias P, Díez JJ. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine. 2007;40:61-70.
16. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf). 2005;62:487-491.
17. Hsieh CJ, Wang PW, Wang ST, et al. Serum leptin concentrations of patients with sequential thyroid function changes. Clin Endocrinol (Oxf). 2002;57:29-34.
18. Iida M, Murakami T, Yamada M, et al. Hyperleptinemia in chronic renal failure. Horm Metab Res. 1996;28:724-727.
19. Stenvinkel P. Leptin and its clinical implications in chronic renal failure. Miner Electrolyte Metab. 1999;25:298-302.
20. Ostlund RE, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age and metabolic covariates. J Clin Endocrinol Metab. 1996;81:3909-3913.
21. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: plasma leptin, obesity, and plasm insulin in type 2 diabetic subjects. J Clin Endocrinol Metab. 1997;82:654-657.
22. Pecoits-Filho R, Nordfors L, Heimbürger O, et al. Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur J Clin Invest. 2002;32:811-817.
23. Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Cheni JB. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs. 2004;27:835-841.
24. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis. 2002;39:1-11.
25. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):S112-S119.
26. Stompór T, Pasowicz M, Sullowicz W, et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis. 2003;41:203-211.
27. Goldblum SE, Reed WP. Host defences and immunologic alterations associated with chronic hemodialysis. Ann Intern Med. 1980;93:597-613.
28. Mege JL, Capo C, Purgus R, Olmer M. Monocyte production of transforming growth factor β in long-term hemodialysis: modulation by hemodialysis membranes. Am J Kidney Dis. 1996;28:395-399.
29. Daichou Y, Kurashige S, Hashimoto S, Suzuki S. Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients. Nephron. 1999;83:237-245.
30. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today. 1993;14:270-274.
31. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion leads to different functional properties. Annu Rev Immunol. 1989;7:145-173.
32. Mosmann TR, Subash S. The expanding universe of T-cell subsets:Th1,Th2 and more. Immunol Today. 1996;17:138-146.
33. Sester U, Sester M, Hauk M, Kaul H, Kohler H, Girndt M. T-cell activation follows Th1 rather Th2 pattern in haemodialysis patients. Nephrol Dial Transplant. 2000;15:1217-1223.
34. Seder RA, Gazzinelli R, Sher A, Paul WE. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminish interleukin-4 inhibition of such priming. Proc Natl Acad Sci U S A. 1993;90:10188-10192.
35. Hsing CH, Hsu CC, Chen WY, Chang LY, Hwang JC, Chang MS. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant. 2007;22:2230-2238.
36. Liu ML, Xu G, Xue SR, Zhong XC, Chen GX, Chen ZJ. Plasma levels of Th1/ Th2 type cytokine are associated with change of prolactin and GH/IGF-I in hemodialysis patients. Int J Artif Organs. 2008;31:303-308.
37. Martín-Romero C, Santos-Alvarez J, Goberna R, Sánchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000; 199:15-24.
38. Rodríguez L, Graniel J, Ortiz R. Effect of leptin on activation and cytokine synthesis in peripheral blood lymphocytes of malnourished infected children. Clin Exp Immunol. 2007;148:478-485.
39. Mattioli B, Straface E, Quaranta MG, Giordani L, Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol. 2005;174:6820-6828.
40. Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis. 2001;38(Suppl 1):80-84.
41. Chopra IJ. Clinical review 86: euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab. 1997;82:329-334.
42. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501-509.
43. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf). 1993;39:499-518.
44. Hashimoto H, Igarashi N, Miyawaki T, Sato T. Effects of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 on type I iodothyronine 50 deiodination in rat thyroid cell line, FRTL-5. J Interferon Cytokine Res. 1995;15:367-375.
45. Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM. Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,30-triiodothyronine syndrome. Endocrinology. 1996;137:5250-5254.
46. Davies PH, Black EG, Sheppard MC, Franklyn JA. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clin Endocrinol (Oxf). 1996;44:199-205.
47. Bartalena L, Brogioni S, Grasso L, Velluzzi F, Martino E. Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest. 1994;17:269-274.
48. Abo-Zenah HA, Shoeb SA, Sabry AA, Ismail HA. Relating circulating thyroid hormone concentrations to serum interleukins- 6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency. BMC Endocr Disord. 2008;8:1.
49. Enia G, Panuccio V, Cutrupi S, et al. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2007;22:538-544.
50. Malyszko J, Malyszko J, Wolczynski S, Mysliwiec M. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related? Nephrol Dial Transplant. 2006;21:145-152.
51. Iglesias P, Alvarez Fidalgo P, Codoceo R, Diez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf). 2003;59:621-629.
52. Santini F, Marsili A, Mammoli C, et al. Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest. 2004;27:RC5-RC7.